The Mounjaro 5ml pen: what the volume actually tells you

Step 1: understand what the 5ml figure means before you open the box

Pick up any Mounjaro pen and you'll see two numbers on the label: the strength (say, 5mg or 10mg) and, less prominently, the volume, 5ml. The volume is fixed. What changes between strengths is the concentration of tirzepatide dissolved in that same 5ml. A 2.5mg pen holds 0.5mg of tirzepatide per ml; a 15mg pen holds 3mg per ml. The injected volume each week is 1.25ml in every case.

This matters for one practical reason: if you're wondering whether you've injected a full dose, the amount of liquid drawn from the pen isn't a reliable guide, it's the same regardless. The full breakdown of how many ml the pen holds and how each dose is measured is worth reading if that question is nagging at you.

One misconception worth addressing gently: some people assume a pen with a higher-milligram label must physically be larger. It isn't. The 5ml KwikPen format is consistent, so a 15mg pen looks and feels identical to a 2.5mg pen in your hand. Dosing isn't managed by swapping pen sizes; it's managed by your prescriber moving you to a higher-concentration cartridge at the right time.

Step 2: prepare properly, storage, needles, and the injection site

The pen should be stored in the fridge at 2–8°C until you're ready to use it. Check the Patient Information Leaflet for the exact window you're allowed to keep it at room temperature, that window exists but the precise figure is medicine-specific and the leaflet is the right place to find it, not a webpage. Remove the pen from the fridge roughly 30 minutes before use; a cold injection is more likely to sting.

Needles are not included with the pen. Mounjaro is injected subcutaneously (just under the skin), and 5mm needles are the standard recommendation for most adults. Attach a fresh needle each time; reusing needles blunts the tip and risks blocked delivery or site irritation. Swab the chosen skin area with an alcohol swab and let it dry before injecting.

Rotate your injection site week to week. Abdomen, thigh, and upper arm are all licensed sites; sticking to the same spot risks small lumps of thickened skin (lipohypertrophy) that can affect how reliably the medicine is absorbed. The injection technique guide covers site rotation and technique in more detail.

Step 3: the injection itself, what to expect from the pen mechanism

The KwikPen is designed to make the injection as straightforward as possible. Once the needle is attached and the cap removed, you press the pen firmly against your skin and activate the dose. The mechanism holds the dose at 1.25ml; you don't measure or draw anything yourself. Hold the pen in place for the count recommended in your leaflet, then withdraw and dispose of the needle immediately in a sharps container.

The pen clicks, but not in the way a single-use auto-injector does. Because the 5ml pen is multi-dose, it has a dose counter on the side showing how many of the four doses remain. Watch that counter rather than trying to estimate how much liquid is left, the counter is more reliable. A full walkthrough of the mechanism is in our guide to using the Mounjaro pen.

Mounjaro is taken once a week, not daily. Consistent weekly timing helps maintain steady levels in the body. If your usual day doesn't work one week, the Patient Information Leaflet sets out the flexibility window, and your prescriber or our aftercare team can help if you're unsure.

Side effects to know about from your first pen

GI symptoms are the most commonly reported effects with tirzepatide: nausea, loose stools, constipation, and indigestion are typical in the early weeks, and they tend to settle as your body adjusts, especially if you're on the 2.5mg starter dose. Eating smaller meals and avoiding very fatty food during that phase helps most people through it, as noted in the NHS's tirzepatide medicines page.

One side effect that warrants urgent attention rather than waiting: severe and persistent stomach pain that radiates toward the back. The MHRA highlighted acute pancreatitis as a known but uncommon risk with GLP-1 medicines in a Drug Safety Update issued in January 2026. If that kind of pain develops, stop the injection and seek medical help promptly, don't assume it's ordinary nausea. You can report any suspected side effects directly at the MHRA Yellow Card scheme.

Injection-site reactions (redness, mild swelling) are usually brief and are one more reason to rotate your injection sites faithfully. If you have questions about a specific reaction, our clinical team is reachable seven days a week. You can read more about the broader Mounjaro treatment picture on our Mounjaro overview page, or explore weight-loss treatment options if you're still weighing up what might suit you.

If you're new to the treatment and want to understand the prescribing process, our free consultation is the next logical step.